2.02
-0.25(-11.01%)
Currency In USD
| Previous Close | 2.27 |
| Open | 1.95 |
| Day High | 2.07 |
| Day Low | 1.83 |
| 52-Week High | 3.87 |
| 52-Week Low | 0.39 |
| Volume | 6.35M |
| Average Volume | 17.08M |
| Market Cap | 147.45M |
| PE | -2.24 |
| EPS | -0.9 |
| Moving Average 50 Days | 1 |
| Moving Average 200 Days | 0.96 |
| Change | -0.25 |
If you invested $1000 in Rani Therapeutics Holdings, Inc. (RANI) since IPO date, it would be worth $183.64 as of November 10, 2025 at a share price of $2.02. Whereas If you bought $1000 worth of Rani Therapeutics Holdings, Inc. (RANI) shares 3 years ago, it would be worth $318.11 as of November 10, 2025 at a share price of $2.02.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Rani Therapeutics to Present Preclinical Data on Oral Delivery of Semaglutide via the RaniPill® Capsule at ObesityWeek® 2025
GlobeNewswire Inc.
Oct 30, 2025 12:00 PM GMT
SAN JOSE, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that
Rani Therapeutics Announces the Appointments of Abe Bassan and Vasudev Bailey, Ph.D. to Board of Directors
GlobeNewswire Inc.
Oct 23, 2025 8:05 PM GMT
SAN JOSE, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced the
Rani Therapeutics Announces Closing of Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules
GlobeNewswire Inc.
Oct 23, 2025 8:01 PM GMT
Financing led by Samsara BioCapital, L.P. (“Samsara”) with participation from additional investors, including RA Capital Management, Anomaly, Special Situations Funds, Invus and Mr. Mir Imran Each of Samsara and Anomaly has the right to designate one